Quantcast

Latest Statin Stories

2014-02-14 23:04:43

New guidelines for prescribing the cholesterol-lowering drugs known as statins no longer focus blood cholesterol value. Instead, the decision should focus on an individual's overall risk of heart disease. Boston, MA (PRWEB) February 14, 2014 For years, doctors prescribed the cholesterol-lowering drugs known as statins based largely on cholesterol test results. But new guidelines from the American Heart Association and the American College of Cardiology propose a major change to that...

2014-02-13 23:02:35

The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of Lipitor. New York, NY (PRWEB) February 13, 2014 As Lipitor lawsuits (http://www.thelipitorlawsuit.com/) continue to mount in the U.S., Bernstein Liebhard LLP notes that Pfizer Inc. is facing additional legal action in Australia over the cholesterol-lowering statin medication. According to a report from Reuters, the Australian Competition and Consumer Commission...

2014-02-12 08:29:41

New Published Study Reveals BergaMet(TM) Added to Statins Enhances Lipid Lowering and Artery Health DENVER, Feb. 12, 2014 /PRNewswire/ -- New published research reveals that a highly concentrated proprietary extract of the Calabrian bergamot fruit called BergaMet(TM) (38% citrus bergamot extract, NathealthSolutions) enhances the effect of the lipid lowering drug rosuvastatin (Crestor(TM)) when given to patients with elevated cholesterol. Led by cardiologists Franco Romeo and Vincenzo Mollace,...

2014-02-10 23:01:08

Flood Law Group released a statement today announcing that they are now investigating claims for patients who developed type-2 diabetes after being prescribed Lipitor. Lipitor belongs to a family of drugs known as “statins,” which have been shown to increase the risk of new-onset diabetes in some cases. (PRWEB) February 10, 2014 Flood Law Group today announced that they are actively investigating claims by any patient who allegedly developed type-2 diabetes after taking the...

2014-02-07 12:55:29

Viruses mutate fast, which means they can quickly become resistant to anti-viral drugs. But viruses also depend on proteins and nutrients provided by their hosts, and therefore one strategy to identify new anti-viral drugs is to identify and target such host-cell components. A paper published on February 6th in PLOS Pathogens reports that proteins involved in the regulation of cholesterol are essential for hantavirus entry into human host cells. There are only about 30 known human cases of...

2014-02-05 11:24:51

An educational toolkit designed to improve care of patients with diabetes was not effective, Baiju R Shah and colleagues (University of Toronto) found in a cluster randomized trial conducted in 2009-2011. During 10 months of follow-up, patients of Canadian family physicians who had been cluster-randomized to receive the toolkit did not receive improved care and their outcomes did not differ compared with patients of physicians who did not receive the toolkit. All 933,789 people aged ≥40...

2014-02-04 11:23:37

Intensive blood pressure and cholesterol lowering was not associated with reduced risk for diabetes-related cognitive decline in older patients with long-standing type 2 diabetes mellitus, according to a study by Jeff D. Williamson, M.D., M.H.S., of the Wake Forest School of Medicine, Winston-Salem, N.C., and colleagues. Patients with type 2 diabetes (T2DM) are at increased risk for decline in cognitive function, for reduced brain volume and increased white matter lesions on brain imaging,...

2014-02-04 08:33:16

Urges Reinstatement of SPA for Heart Drug Vascepa NEW YORK, Feb. 4, 2014 /PRNewswire-USNewswire/ -- The EPA Drug Initiative (EPADI) asserts that the FDA did not live up to its own scientific integrity standards in rescinding the Special Protocol Assessment (SPA) related to the "ANCHOR" sNDA for the triglyceride (TG) lowering drug, Vascepa, and urges that the Agency adhere to its own policies in the appeal of the SPA rescission decision. (Photo:...

2014-02-02 23:01:23

The attorneys at Bernstein Liebhard LLP are investigating claims by potential Lipitor lawsuit claimants who may have developed Type 2 diabetes after taking the cholesterol-lowering statin. New York, NY (PRWEB) February 02, 2014 Plaintiffs in Lipitor lawsuits (http://www.thelipitorlawsuit.com/) continue to wait for a federal Panel’s decision on whether to consolidate cases over the cholesterol drug after inclement weather caused last week’s hearing on the matter to be postponed,...

2014-01-30 16:26:43

RUTHERFORD-2 Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Jan. 30, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 RUTHERFORD-2 (RedUction of LDL-C with PCSK9 InhibiTion in HEteRozygous Familial HyperchOlesteRolemia Disorder Study-2) trial evaluating evolocumab in combination with statins and other lipid-lowering therapies in patients with heterozygous familial hypercholesterolemia (HeFH) met its co-primary...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related